LEAH drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

ethinylestradiol, Quantity: 20 microgram; drospirenone, Quantity: 3 mg

Disponible des:

Bayer Australia Ltd

Designació comuna internacional (DCI):

Drospirenone,ethinylestradiol

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; purified talc; microcrystalline cellulose

Vía de administración:

Oral

Unidades en paquete:

1 x 28 tablets, 3 x 28 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

LEAH is indicated for use as: - an oral contraceptive. - treatment of moderate acne vulgaris in women who seek oral contraception - treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who have chosen oral contraceptives as their method of birth control. The efficacy of LEAH for PMDD was not assessed beyond 3 cycles. LEAH has not been evaluated for treatment of PMS (premenstrual syndrome), see CLINICAL TRIALS.

Resumen del producto:

Visual Identification: Small round white tablet debossed on one side with the letters "DP" in a regular hexagon.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Estat d'Autorització:

Licence status A

Data d'autorització:

2014-08-04